Haley Schwartz

LSI, BioscienceLA, #LAMedtechweek, and HLTH's #VIVE2024 event resulted in the latest GTM Pulse Check offering which has successfully taken off! As a result, I am continuing on last week's series of go-to-market tactics. Crafting a robust marketing plan is essential for medical device companies to thrive in today's world. By leveraging these outlined sections, organizations can optimize their marketing strategies and drive meaningful impact.This post takes a step back to outline the sections of a marketing plan. Read on 👇🏼 Looking for support in creating your marketing plan?  Let’s chat! Book here 👉🏼 https://lnkd.in/g92YA9WK _____ P.S. Enjoying my content? ⚕️Follow me for more tips on medical device commercialization and repost to share with your network. #medtech #gotomarket #medicaldevices #healthcareinnovation

27

2 Comments

Hailing all Defenders of the Detrusor ... More tools in your toolbelt! Yes ... the Golden Era of Bladdder Diagnostics for BPH BPO is alive and well! The category of Basic Urodynamics continues to grow as it includes ... IPSS, Diary, PSA, Uroflow, and Ultrasound (DWT, BWT, PV, IPP, PL. etc.) ! Use #Uroflow as an additional data point to triage LUTS patients and identify who needs a Bladder Health Baseline which included at least a #cystoscopy and ideally multi-channel Advanced #urodynamics if available. If you have Enhanced UDS like penile cuff or external condom catheter technology, then use that. Any data is better than none. Great listen as the Brigade of Uroflow Defenders keep advancing both the hardware and software technologies to empower BPH BPO patients with their own data !!! Amazing how the technologies can account for so many parameters ... Patient Height | Echoic properties | Water depth | Shape of toilet bowls | Background noice | Meatal geometry | Water depth ... Nice! Defenders, find the technology that works for your BPH BPO operational pathway. Most importantly, keep prioritizing DATA OVER DRUGS!!!! #stopnarcotizingbladders Luca Cindolo Drugs are Temporizing measures, not Therapeutic measures. Data shines light into the darkness of BPH BPO. Accurate data drives appropriate decision-making! Let's go save more bladders!! Shout out to Emano Flow and the visionary team they have assembled Bishara Korkor, MS Teddy Hay, PhD Kevin McVary Alexander Glaser Chuck Schwiesow DPT, CMTPT, ATC Gratitude for the growth of the Uroflow Brigade of Defenders Stream Diagnostic - Empowering urologists to further the conversation Mark W. Robinson Austen Slade, MD, MBA MenHealth Jenny Belotserkovsky Sijo Parekattil M.D., FACS Soundable Health Catherine J Song Bilal Chughtai Ricardo R Gonzalez MD URPS iO Urology Corp Britton GarrettSteven Kaplan Minze Health Gilles Tas Tip of the hat to and appreciation for Master Interviewer John Lin, MD ... The microphone technique ... the eye contact ... the interview questions ... So much to learn in this Crusade to Save Bladders. ______ Let’s evolve the Guidelines together… Prioritizing the Preservation of Bladder Health Ending the Polypharmacy Epidemic and Preventing Late-Stage BPH BPO / End-Organ Bladder Failure(Patient-Centered Medicine) (Stg1 BPO Stg 2 Overactive Bladder Stg 3 Urge Incontinence, Stg 4 Acute Retention, Stg 5 Bladder Failure) ________ Learn more: https://lnkd.in/gsFnAhvZ #WhatAboutMyBladder #manvsprostate #prostate #bph #urology #bladder #bladderhealth #menshealth

6

Product Positioning is often confused for Value Proposition and while some of the components overlap, both are necessary for a bulletproof go-to-market strategy. Check out the graphic below and work clockwise around the hive to ask yourself key questions about launching the next medical device in your portfolio👇🏼 Interested in learning more?  Let’s chat! Book here 👉🏼 https://lnkd.in/g92YA9WK _____ P.S. Enjoying my content? ⚕️Follow me for more tips on medical device commercialization and repost to share with your network. #medtech #gotomarket #medicaldevices #healthcareinnovation

12

2 Comments

Effective patient engagement requires a multifaceted approach that prioritizes user involvement at every stage of the healthcare journey. One key strategy is personalized communication, which can be facilitated by AI-driven platforms that analyze patient data to deliver tailored messages and recommendations. These platforms can send reminders for medication adherence, provide educational content relevant to the patient's condition, and offer motivational messages to encourage healthy behaviors. Discover how AI-driven platforms are revolutionizing patient engagement and transforming healthcare delivery by reading the full article. https://buff.ly/3XcXqef #healthtech #investing #AIwellness #digitalhealth #ecommerce #investmentstrategies #wellnessindustry #AItechnology Subscribe to the Evolving HealthTech newsletter here: https://buff.ly/44pGPE0

7

Here's another fundraising roundup spotted in the healthcare wilds 👀 🍃 ✅ Sword Health raised $130M (new valuation: $3B). ✅ Better Health raised $14M to deploy expanded payer partnerships. ✅ Alzheon, Inc. | Preserving Future Memories raised $100M Series E to advance development & commercialization of its Alzheimer’s treatment. ✅ CinRx Pharma raised $73M to continue its ‘Hub and Spoke’ model of startup formation. ✅ Eko Health raised $41M to scale AI-driven heart and lung disease detection. ✅ Anterior (formerly Co:Helm) secured a $20M Series A to unlock admin efficiencies for healthcare payers. ✅ SamaCare raised a $17M Series B to scale specialty drug prior authorization platform. ✅ Plenful secured a $17M Series A to streamline pharmacy operations with AI-powered workflow automation. ✅ Grayce raised a $10.4M Series A led by Maveron amid a caregiving crisis. ✅ Stitch Employment Services Inc PEO raised $8.75M in seed to support independent medical practices. ✅ Posterity Health secured $6M to fund expansion and technology acceleration. ✅ Sware raised $6M to accelerate life sciences innovation by automating FDA-mandated software validation. ✅ Keragon raised $3M, as announced in @Conno Christou’s LinkedIn post. As always, if I missed you, let me know! Each week I'm spotlighting an innovative healthcare startup. I just ask for a bit more transparency. All submissions are confidential; submit yours here 👇 https://lnkd.in/gF4DrAvJ Looking for more fundraising roundups, alongside healthcare industry news and analysis? Subscribe to Hospitalogy, my 2x/week newsletter. Join 33K+ other investors, executives, and healthcare professionals: https://lnkd.in/g-nfRqW6

39

3 Comments

We need to highlight more bootstrapped healthcare companies. I rarely see founders of these small businesses profiled at conferences or in the media. The chances of building a $100M+ revenue healthcare company are very slim. But that’s the expectation once you accept VC funding (especially Series A and beyond). Let me remind you, most healthcare companies do lower revenue than total capital raised. And you can build a wonderful life and help your community with much lower revenue / growth, if you take minimal or no funding. And believe it or not, most VC-backed founders are fascinated by founders and business models that didn’t require external capital. Do you agree? Or would you prefer media and “influencers” to focus on venture-backed and publicly traded companies? Sometimes I feel like I’m shouting out into the void. Because majority of content is focused on the unicorn chasers. Would love to hear from founders of bootstrapped companies in the comments?

303

108 Comments

🚀 Exciting Milestone Alert for the MedTech & Pharmaceutical Industry! I'm beyond excited to share some major news with you all! After a journey filled with intense data gathering and analysis, our dedicated team at Vamstar has hit a monumental milestone. We've now got an incredible opportunity to bring something truly groundbreaking to the MedTech and Pharmaceutical industries. With pricing challenges significantly impacting these sectors—evident in the steep decline in net margins by over 15% over the last decade and the rising costs of operations—our breakthrough couldn't have come at a more crucial time. We're witnessing a transformative shift in our industry, with a strong move towards more tighter engagement with healthcare professionals (HCPs) and even extending to home environment (Care moving to home). This necessary evolution, however, suggests that the expenses involved in doing business are set to climb even higher (further eroding net margins). Now more than ever, a deep dive into the intricacies of pricing and portfolios, coupled with strategies aimed at fostering both growth and sustainability, is absolutely essential. Yet, this is where many pricing teams hit a roadblock—due to a stark lack of vital data, insights, and the right tools. But that's about to change. Enter Vamstar's Pricing Co-Pilot: https://lnkd.in/e5JvmxZV By harnessing the power of artificial intelligence, this trailblazing tool is set to revolutionise how we tackle pricing in our field. It's meticulously crafted to bridge the gap, offering the much-needed insights, data, and tools that have been missing from the equation. With Pricing Co-Pilot, informed decision-making becomes faster and more effective, marking a significant leap forward in our approach to pricing. Let's dive into this new era together! 📅 Ready to revolutionise your pricing strategy? For a detailed demo or insights about various case studies of what Pricing Co-Pilot can do for your organisation, or if you're simply eager to learn more, please feel free to book a session with me or just drop a "yes" in the comments below. Let's navigate the future of MedTech and Pharmaceutical pricing together! #MedTech #Pharmaceuticals #PricingStrategy #Innovation #AI #Vamstar #BusinessGrowth #Sustainability

22

1 Comment

Conservative intervention vs. surgical intervention is a frequently debated topic but the third category is “no intervention at all”. More often than the healthcare industry wants to admit, many American go without intervention at all due to: Cost Access Limited support (available caregivers) What are solutions to this problem? Free market transparent pricing and regulations that expand remote access would be a great start. What are your thoughts? #healthcare

4

The Healthcare Stage I Episode 9(1) I Introducing Pulsar Medtech's innovative bone growth stimulation device for fresh fractures treatment   🎙️  Join us for an enlightening conversation with Elad Yakobson, CEO of Pulsar Medtech, a cutting-edge Israeli startup aiming to revolutionize fracture treatment with their Bone Growth Stimulation devices. Discover how Pulsar Medtech's lightweight patches are enhancing patient comfort and compliance, addressing challenges with current devices and potentially improving clinical outcomes. With FDA approval on the horizon, Pulsar Medtech aims to tap into a $500 million market annually, with even larger prospects in treating fresh fractures. Learn about the safety and efficacy of their innovative device, backed by rigorous clinical studies, and their upcoming pivotal study in the US in 2024. For investors seeking opportunities in the MedTech sector, this podcast offers valuable insights into Pulsar Medtech's trajectory and growth potential. I would like to personally thank Google campus in Tel Aviv for hosting us and for their ongoing support in innovative Israeli life science companies. 🎧Podcast is available on “The Healthcare Stage” YouTube channel, Spotify and Apple podcast   #TheHealthcareStage #MedTech #HealthcareInnovation #BoneHealing #Bonegrowthstimulation #Fractures #orthopedicpatients #VC #Investment #Startup #PulsarMedtech https://lnkd.in/d_H4nrrt

12

1 Comment

The Wild Ride of Rapid Growth: Transitioning from Founder to CEO! Starting a digital health company is exhilarating, with late nights, bold ideas, and relentless pursuit of success. But when dreams materialize faster than expected, the excitement is matched by the reality of rapid scaling. Here’s my experience navigating this whirlwind and the shifts required to keep up. Embrace the Shift: From Doer to Leader In the beginning, an entrepreneur wears many hats—visionary, marketer, accountant, even coffee runner. But as your business takes off, demands grow exponentially. The first major shift is realizing you can't do it all. Letting Go of Control: To scale effectively, you must delegate tasks to experts. This means hiring the right personnel to manage various aspects of the business. Thinking Big: The CEO's New Role As your team takes over operations, your role evolves. Your focus shifts to steering growth and strategic direction. Visionary Thinking: Anticipate market trends and plan the next big moves. Building Relationships: Nurture relationships with clients, investors, and peers to drive growth. Strategic Decision-Making: Make high-impact decisions shaping the company’s future. The Wild Ride Scaling rapidly is thrilling but daunting. The pace can be overwhelming, and the stakes are high. However, the rewards are immense. Seeing your idea grow, your team thrive, and your hard work pay off is unparalleled. Building Your Dream Team To sustain rapid growth, you need a supportive team. Key roles include: Accounting Marketing Sales Administration Legal Human Resources Customer Support Technology/IT Operations Management Product Development Adaptability and Resilience: Stay adaptable and resilient. Learn from setbacks, celebrate wins, and keep pushing forward. Balance and Well-being: Maintain balance. Prioritize your well-being, stay connected with your support system, and find time to recharge. A healthy leader is essential for a thriving business. In conclusion, transitioning from a solo entrepreneur to the CEO of a rapidly growing company is a wild ride. It requires a significant mindset shift, the right team, and relentless focus on the bigger picture. Embrace the chaos, enjoy the ride, and keep pushing boundaries. The rewards are well worth the effort. LIVEMED Telehealth™ #physicianleader #CEO #Founder #healthcareinnovation #startups #entrepreneurship #digitalhealth

50

4 Comments

Investing in companies that fill needs for health systems is a growth opportunity for both delivery organizations and start ups. Some systems are jumping in on their own, while others are partnering with like minded systems or with established VC firms. While this is a relatively new trend for systems, health plans have been making similar bets for many years. The benefits of becoming a health system portfolio company can be significant. Data, access to beta populations and real world coaching can be extremely beneficial. Start ups get mentoring and systems have to ability to leverage outside resources to solve relevant business problems. I predict a booming business!

4

The role of AI and new technology to aid cardiology “As cardiology starts to face staffing shortages and continued decreases in CMS payments, Biga believes technology advances need to be leveraged in cardiology to help improve outcomes, make workflows more efficient to do more with less, and to help cut costs.” “Many of the solutions that can help were displayed on the expo floor, including telehealth and real-time remote monitoring systems. "I think this area will experience an explosion in use," Biga said. Another major area that will likely see an explosion of use is artificial intelligence (AI). She said AI will begin playing a rapidly growing role in cardiology in the coming years to augment cardiologists and other clinical staff. And not just on the front lines of patient care, but also in the back offices where AI will play a growing role in IT systems, smoothing workflow, analytics, automated quality metrics capture and many other areas. "We must use AI to reduce administrative burdens and improve patient outcomes," Biga explained. “

17

1 Comment

Dear LinkedIn Community, In the ever-evolving landscape of healthcare, particularly in the realm of urology and prostate cancer treatment, there exists a critical need for innovation and optimization. As a seasoned consultant specializing in healthcare, with a focus on urology and prostate cancer, I am deeply passionate about bridging the gap between current practices and the dynamic changes in treatment modalities. Addressing the Void: Providers and clinicians often find themselves grappling with the challenges of keeping pace with the rapid advancements in prostate cancer treatment. With emerging therapies and evolving guidelines, there is a pressing need for robust processes and strategies to ensure optimal patient care delivery. This void underscores the necessity for tailored solutions that empower healthcare providers to adapt and thrive in this ever-changing landscape. Empowering Advance Practice Professionals (APPs): Advance Practice Professionals (APPs), including Nurse Practitioners (NPs) and Physician Assistants (PAs), play a crucial role in meeting the evolving needs of communities and patients. By leveraging their clinical expertise and scope of practice, APPs have the potential to drive significant improvements in prostate cancer care. From creating specialized clinics focused on advanced prostate cancer management to providing personalized patient education and support, APPs are instrumental in enhancing access to high-quality care. Guiding Business Growth: As a consultant, I am dedicated to guiding healthcare organizations in harnessing the full potential of APPs to drive business growth. By developing strategic initiatives tailored to the unique needs of each practice, we can optimize workflows, streamline processes, and enhance patient satisfaction. From onboarding and training APPs to integrating them into leadership roles and decision-making processes, I work collaboratively with healthcare teams to unlock new opportunities for growth and innovation. Looking Towards the Future: The future of prostate cancer care hinges on our ability to embrace change, innovate, and collaborate effectively. By empowering healthcare providers with the tools, resources, and support they need to navigate this dynamic landscape, we can ensure that every patient receives the highest standard of care. Together, we can drive meaningful advancements in prostate cancer treatment and make a lasting impact on the lives of patients and communities. Connect with Me: If you are seeking guidance in optimizing prostate cancer care delivery, enhancing practice efficiency, or leveraging the expertise of Advance Practice Professionals, I invite you to connect with me. Together, let us embark on a journey towards transformative change in healthcare. Warm regards, Jeff Phillips Co-Owner and President Urologic Solution Group Consultant in Healthcare Optimization Urology & Prostate Cancer Specialist https://lnkd.in/eVB7yM6R

2

1 Comment